FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented: using benzophenanthridine alkaloid salts for preparing therapeutic agents for treating tumours, wherein the alkaloid salt is found in the form luteic, phosphatidic or hyaluronic acid, the benzophenanthridine alkaloid salt with phosphatidic acid or hyaluronic acid, and a based pharmaceutical composition for treating tumours.
EFFECT: what is shown is cytotoxic activity of the sanguinarine salts according to the invention at least twice increased in all studied tumour cell lines in relation to the chloride salt; it is suggested to be caused by higher absorption by the tumour cells.
12 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR MUCOSITIS INDUCED BY ANTITUMOUR OR IMMUNOSUPPRESSIVE THERAPY | 2009 |
|
RU2460535C2 |
| METHODS OF TREATING AND PREVENTING MUCOSITIS BY ANTHOCYANIDIN DERIVATIVES | 2007 |
|
RU2438693C2 |
| COMPOSITIONS WITH SANGUINARINE, CHELERYTHRINE OR CHELIDONINE FOR TREATMENT OF WARTS, PAPILLOMAS AND PSORIATIC PLAQUES | 2009 |
|
RU2486898C2 |
| COMPOSITIONS FOR TREATING VAGINAL INFECTIONS WITH CHRONIC INFLAMMATION | 2009 |
|
RU2504379C2 |
| COMPOSITIONS FOR TREATING UPPER AIRWAYS DISEASES AND INFLUENZA SYMPTOM COMPLEX | 2009 |
|
RU2518738C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| METHOD OF PREVENTION AND/OR TREATMENT OF CANCEROUS DISEASES | 2006 |
|
RU2480201C2 |
| IMPLANTED PRODUCTS, CONTAINING NANOPARTICLES | 2009 |
|
RU2524644C2 |
| ANTI-CANCER THERAPY, DIRECTED AGAINST CANCER STEM CELLS AND FORMS OF CANCER, RESISTANT TO TREATMENT BY MEDICATIONS | 2010 |
|
RU2568834C2 |
| COMPOSITIONS FOR TREATING AND PREVENTING ORAL INFECTIONS | 2009 |
|
RU2504378C2 |
